Visceral adiposity in postmenopausal women is associated with a pro-inflammatory gut microbiome and immunogenic metabolic endotoxemia/Experiment 1

From BugSigDB


Needs review

Curated date: 2024/10/24

Curator: Vandana Maddi

Revision editor(s): Vandana Maddi, KateRasheed

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Visceral adipose tissue measurement Visceral adipose tissue measurement,visceral adipose tissue measurement
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Low Visceral Adiposity Tissue (VAT) group (Control/Unexposed group).
Group 1 name Corresponds to the case (exposed) group for case-control studies
High Visceral Adiposity Tissue (VAT) group (Case/Exposed group)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
The high visceral adiposity tissue (VAT) group represents women with elevated visceral adipose tissue, which is associated with pro-inflammatory gut microbiome characteristics and metabolic endotoxemia
Group 0 sample size Number of subjects in the control (unexposed) group
25
Group 1 sample size Number of subjects in the case (exposed) group
25
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
3 months

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
Matched on Factors on which subjects have been matched on in a case-control study
age, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged

Signature 1

Needs review

Curated date: 2024/10/24

Curator: Vandana Maddi

Revision editor(s): Vandana Maddi, KateRasheed

Source: Fig. 3E, Fig. 4b

Description: Differential abundant taxa between women with Low Visceral Adiposity Tissue and High Visceral Adiposity Tissue

Abundance in Group 1: increased abundance in High Visceral Adiposity Tissue (VAT) group (Case/Exposed group)

NCBI Quality ControlLinks
Emergencia
Klebsiella
Parabacteroides
Parasutterella
Pseudomonadota
Shigella
uncultured Burkholderia sp.

Revision editor(s): Vandana Maddi, KateRasheed

Signature 2

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-11-28

Curated date: 2024/10/24

Curator: Vandana Maddi

Revision editor(s): Vandana Maddi, KateRasheed

Source: Fig. 4b

Description: Differential abundant taxa between women with Low Visceral Adiposity Tissue and High Visceral Adiposity Tissue

Abundance in Group 1: decreased abundance in High Visceral Adiposity Tissue (VAT) group (Case/Exposed group)

NCBI Quality ControlLinks
Anaerostipes
Barnesiella
Desulfovibrio
Intestinimonas
Massiliimalia
Negativibacillus

Revision editor(s): Vandana Maddi, KateRasheed